Coinfection with HIV-1 alleviates iron accumulation in patients with chronic hepatitis C virus infection

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Liu, Yuan ^a,b   Lv, Quanjun ^b   Gao, Jian ^a   Long, Lu ^a   Duan, Zhaojun ^a   Liang, Hua ^c   Shen, Tao ^a   Lu, Fengmin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; HEPCIDIN; IRON; TRANSFERRIN; IRON BINDING PROTEIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; TRANSFERRIN BLOOD LEVEL; BLOOD; CHRONIC HEPATITIS C; COMPLICATION; HEPACIVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MIDDLE AGED; VIROLOGY;

ADULT; CHINA; COINFECTION; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HEPCIDINS; HIV; HIV INFECTIONS; HUMANS; IRON; IRON-BINDING PROTEINS; MALE; MIDDLE AGED;

EID: 84903188069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098039     Document Type: Article

References (34)

1. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567. (Pubitemid 41196755)
2. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, et al. (2002) Mechanisms of hepatotoxicity. Toxicol Sci 65: 166-176. (Pubitemid 34121108)
3. Nelson JE, Klintworth H, Kowdley KV (2012) Iron metabolism in Nonalcoholic Fatty Liver Disease. Curr Gastroenterol Rep 14: 8-16.
4. Fujita N, Sugimoto R, Urawa N, Araki J, Mifuji R, et al. (2007) Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol 22: 1886-1893. (Pubitemid 47525078)
5. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127: S35-50. (Pubitemid 39423368)
6. Ufearo H, Kambal K, Onojobi GO, Nouraie M, Agbemabiese C, et al. (2010) Complete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity. Clin Chim Acta 411: 653-656.
7. Venturini D, Simao AN, Barbosa DS, Lavado EL, Narciso VE, et al. (2010) Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C. Dig Dis Sci 55: 1120-1127.
8. Drakesmith H, Prentice A (2008) Viral infection and iron metabolism. Nat Rev Microbiol 6: 541-552. (Pubitemid 351863367)
9. Mueller S (2010) Increased iron in HCV infection: collateral damage or antiviral defense? J Hepatol 53: 990-992.
10. Fillebeen C, Rivas-Estilla AM, Bisaillon M, Ponka P, Muckenthaler M, et al. (2005) Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus. J Biol Chem 280: 9049-9057. (Pubitemid 40409598)
11. Galli A, Svegliati-Baroni G, Ceni E, Milani S, Ridolfi F, et al. (2005) Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 41: 1074-1084. (Pubitemid 40593915)
12. Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, et al. (2009) Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 51: 845-852.
13. Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, et al. (1995) Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108: 1104-1109.
14. Bonkovsky HL (2002) Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol 97: 1-4.
15. Bonkovsky HL, Banner BF, Rothman AL (1997) Iron and chronic viral hepatitis. Hepatology 25: 759-768. (Pubitemid 27106467)
16. Bonkovsky HL, Lambrecht RW (2000) Iron-induced liver injury. Clin Liver Dis 4: 409-429, vi-vii. (Pubitemid 30460830)
17. Ganz T (2011) Hepcidin and iron regulation, 10 years later. Blood 117: 4425-4433.
18. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093. (Pubitemid 40007660)
19. McDermid JM, Jaye A, Schim van der Loeff MF, Todd J, Bates C, et al. (2007) Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr 46: 498-507. (Pubitemid 350098703)
20. De Monye C, Karcher DS, Boelaert JR, Gordeuk VR (1999) Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS 13: 375-380. (Pubitemid 29095100)
21. Wisaksana R, Sumantri R, Indrati AR, Zwitser A, Jusuf H, et al. (2011) Anemia and iron homeostasis in a cohort of HIV-infected patients in Indonesia. BMC Infect Dis 11: 213.
22. Gordeuk VR, Delanghe JR, Langlois MR, Boelaert JR (2001) Iron status and the outcome of HIV infection: an overview. J Clin Virol 20: 111-115. (Pubitemid 32106864)
23. Kagu MB, Khalil MI, Ahmed SG (2007) Bone marrow macrophage iron stores in patients with HIV infection and AIDS-associated Kaposi's sarcoma. Afr J Med Med Sci 36: 125-128.
24. Pietrangelo A (2007) Hemochromatosis: an endocrine liver disease. Hepatology 46: 1291-1301.
25. Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, et al. (2007) Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Haematologica 92: 1037-1042. (Pubitemid 350144209)
26. Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, et al. (2010) Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116: 1574-1584.
27. Drakesmith H, Prentice AM (2012) Hepcidin and the iron-infection axis. Science 338: 768-772.
28. Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, et al. (2007) Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Mol Med 13: 97-104. (Pubitemid 46786838)
29. Stebbing J, Gazzard B, Douek DC (2004) Where does HIV live? N Engl J Med 350: 1872-1880.
30. Dallalio G, Law E, Means RT Jr (2006) Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood 107: 2702-2704.
31. P Kosaralaksa TB, Apornpong T, Vibol U, Hansudewechakul R, et al. (2011) Improved in iron status and anemia in HIV-infected children after zidovudine-containing HAART without routine iron supplementation. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Rome, Italy, 17-20 July.
32. McNabb JC, Cappa JA, Ross JW (2001) Disorders of iron metabolism associated with protease inhibitor therapy. Clin Infect Dis 33: 413-414. (Pubitemid 32664854)
33. Wisaksana R, de Mast Q, Alisjahbana B, Jusuf H, Sudjana P, et al. (2013) Inverse relationship of serum hepcidin levels with CD4 cell counts in HIV-infected patients selected from an Indonesian prospective cohort study. PLoS One 8: e79904.
34. Xu M, Kashanchi F, Foster A, Rotimi J, Turner W, et al. (2010) Hepcidin induces HIV-1 transcription inhibited by ferroportin. Retrovirology 7: 104.